October 21, 20 - 8:04 pm - LABS

Pfizer and BioNTech to produce 2 million COVID-19 vaccines to Ecuador

The pharmaceuticals Pfizer and BioNTech announced on Wednesday an agreement with the Ecuadorian government to supply an mRNA-based vaccine against COVID-19, reported Dialoguemos. The vaccine is still subject to the success of the clinical trials and regulatory approval.

The Ecuadorian government will receive 2 million doses after authorization from the National Agency for Health Regulation, Control, and Surveillance (Arcsa, in Spanish). The media outlet says that financial details were not disclosed and deliveries of the vaccine will be made progressively until 2021.